Triple-combination treatment with olmesartan medoxomil/amlodipine/ hydrochlorothiazide in hispanic/latino patients with hypertension: The trinity study

Ethnicity and Disease

Volumn 24, Issue 1, 2014, Pages 41-47

  Lewin, Andrew J ^a   Kereiakes, Dean J ^b   Chrysant, Steven G ^c   Izzo Jr , Joseph L ^d   Oparil, Suzanne ^e   Lee, James ^f   Fernandez, Victor ^f   Melino, Michael ^f  

^a NATIONAL RESEARCH INSTITUTE   (United States)

^b The Carl & Edyth Lindner Center for Research & Education   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f DAIICHI SANKYO INC   (United States)

Author keywords

Angiotensin receptors; Calcium channel blockers; Hispanic americans; Hypertension; Thiazide diuretics

Indexed keywords

AMLODIPINE PLUS HYDROCHLOROTHIAZIDE PLUS OLMESARTAN;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HEADACHE; HISPANIC; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OPEN STUDY; PARALLEL DESIGN; PERIPHERAL EDEMA; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; URINARY TRACT INFECTION;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; DOUBLE-BLIND METHOD; FEMALE; HISPANIC AMERICANS; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; IMIDAZOLES; LEAST-SQUARES ANALYSIS; MALE; MIDDLE AGED; TETRAZOLES;

EID: 84893465133     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics - 2013 update - a report from the American Heart Association. Circulation. 2013;127(1):143-152.
2. Wrobel MJ, Figge JJ, Izzo JL, Jr. Hypertension in diverse populations: a New York State Medicaid clinical guidance document. J Am Soc Hypertens. 2011;5(4):208-229.
3. Ennis SR, Rios-Vargas M, Albert NG. The Hispanic population: 2010. United States Census Bureau. www.census.gov/prod/cen2010/briefs/c2010br-04.pdf. Accessed May 7, 2013.
4. Guzman NJ. Epidemiology and management of hypertension in the Hispanic population: a review of the available literature. Am J Cardiovasc Drugs. 2012;12(3):165-178.
5. Crespo CJ. Hypertension among Hispanics. Presented at: Latino Health Equity Conference; 5-12-2011; Portland, OR.
6. Centers for Disease Control and Prevention. Vital signs: awareness and treatment of uncontrolled hypertension among adults - United States, 2003-2010. MMWR Morb Mortal Wkly Rep. 2012;61:703-709.
7. Barnes DM, Lu JH. Mexican immigrants' and Mexican Americans' perceptions of hypertension. Qual Health Res . 2012;22(12): 1685-1693.
8. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. (Pubitemid 37553153)
9. Hypertension-related mortality among Hispanic subpopulations - United States, 1995-2002. MMWR Morb Mortal Wkly Rep. 2006;55(7):177-180.
10. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens. 2009;27(11):2121-2158.
11. Gu Q, Burt VL, Dillon CF, Yoon S. Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010. Circulation . 2012;126(17):2105-2114.
12. Oparil S, Melino M, Lee J, Fernandez V, Heyrman R. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: the TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study. Clin Ther. 2010;32(7):1252-1269.
13. Kereiakes DJ, Chrysant SG, Izzo JL, Jr., et al. Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide for hypertension. J Clin Hypertens. 2012;14(3):149-157.
14. Summary of revisions for the 2013 clinical practice recommendations. Diabetes Care. 2013;36 Suppl 1:S3.
15. Davidson JA, Moreno PR, Badimon JJ, et al. Cardiovascular disease prevention and care in Latino and Hispanic subjects. Endocr Pract. 2007;13(1):77-85.
16. Morenoff JD, House JS, Hansen BB, Williams DR, Kaplan GA, Hunte HE. Understanding social disparities in hypertension prevalence, awareness, treatment, and control: the role of neighborhood context. Soc Sci Med. 2007;65(9):1853-1866. (Pubitemid 47516620)
17. Punzi H, Shojaee A, Maa JF. Efficacy and tolerability of fixed-dose amlodipine/olmesartan medoxomil with or without hydrochlorothiazide in Hispanic and non-Hispanic patients whose blood pressure is uncontrolled on antihypertensive monotherapy. Ther Adv Cardiovasc Dis. 2012;6(4):149-161.
18. Ofili EO, Oparil S, Giles T, et al. Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups. J Am Soc Hypertens . 2011;5(4):249-258.
19. Wright JT, Jr., Lacourciere Y, Samuel R, Zappe D, Purkayastha D, Black HR. 24-Hour ambulatory blood pressure response to combination valsartan/hydrochlorothiazide and amlodipine/hydrochlorothiazide in stage 2 hypertension by ethnicity: the EVALUATE study. J Clin Hypertens (Greenwich). 2010;12(11):833-840.
20. Margolis KL, Piller LB, Ford CE, et al. Blood pressure control in Hispanics in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2007;50(5):854-861. (Pubitemid 350287526)
21. Weinick RM, Zuvekas SH, Cohen JW. Racial and ethnic differences in access to and use of health care services, 1977 to 1996. Med Care Res Rev. 2000;57 Suppl 1:36-54.
22. Horowitz CR, Tuzzio L, Rojas M, Monteith SA, Sisk JE. How do urban African Americans and Latinos view the influence of diet on hypertension? J Health Care Poor Underserved. 2004;15(4):631-644. (Pubitemid 39531409)
23. Anderson JB. Unraveling health disparities: examining the dimensions of hypertension and diabetes through community engagement. J Health Care Poor Underserved. 2005;16(4 Suppl A):91-117. (Pubitemid 41820325)
24. Okonofua EC, Simpson KN, Jesri A, Rehman SU, Durkalski VL, Egan BM. Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals. Hypertension. 2006;47(3):345-351. (Pubitemid 43740273)
25. Eamranond PP, Legedza AT, Diez-Roux AV, et al. Association between language and risk factor levels among Hispanic adults with hypertension, hypercholesterolemia, or diabetes. Am Heart J. 2009;157(1):53-59.
26. Yang Y, Thumula V, Pace PF, Banahan BF, III, Wilkin NE, Lobb WB. Nonadherence to angiotensin-converting enzyme inhibitors and/ or angiotensin II receptor blockers among high-risk patients with diabetes in Medicare Part D programs. J Am Pharm Assoc. 2010;50(4):527-531.
27. Perez A. Self-management of hypertension in Hispanic adults. Clin Nurs Res. 2011;20(4):347-365.
28. Fung V, Huang J, Brand R, Newhouse JP, Hsu J. Hypertension treatment in a Medicare population: adherence and systolic blood pressure control. Clin Ther . 2007;29(5):972-984. (Pubitemid 47223429)
29. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-719. (Pubitemid 47176510)
30. Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension . 2010;55(2):399-407.